Document:

Exhibit 10.2

                          EXCLUSIVE OPTION AGREEMENT

   This Exclusive Option Agreement (hereinafter called "Agreement"), to be
effective as of the 14th day of April, 2008 (hereinafter called "Effective
Date"), is by and among The Cleveland Clinic Foundation (hereinafter, "CCF")
with its principal location at 9500 Euclid Ave., Cleveland, Ohio 44195 and
IVPSA, with its principal location at 500 N. Rainbow, Suite 300,
Las Vegas, NV 89107 (hereinafter, "OPTIONEE").  Collectively, both
entities may hereinafter be referred to as "Party" or "Parties."

RECITALS:
---------

   Whereas, CCF owns the Licensable Technology as defined below;

   Whereas, OPTIONEE specializes in developing technology and bringing new
technologies to market;

   Whereas, OPTIONEE desires to investigate and conduct due diligence with
respect to the commercial viability of the Licensable Technology prior to
executing the License Agreement;

   NOW, THEREFORE, for and in consideration of the premises and other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, and intending to be legally bound hereby, the Parties hereto
expressly agree as follows:

1.  DEFINITIONS
    -----------

   A. "Affiliates" means any corporation or other business entity which
controls, is controlled by or is under common control with OPTIONEE.  For
purposes of this Section 1.1, "control" shall mean direct or indirect ownership
of (i) at least fifty percent (50%) of the outstanding stock or other voting
rights entitled to elect directors, or (ii) in any country where the local law
shall not permit foreign equity participation of at least fifty percent (50%)
then the maximum percentage of such outstanding stock or voting rights
permitted by local law.

   B. "Confidential Information" means any confidential or proprietary
information furnished by one party (the "Disclosing Party") to the other party
(the "Receiving Party") in connection with this Agreement, provided that such
information is specifically designated as confidential.  Confidential
Information shall include, but not be limited to, the following when
specifically designated as confidential:  business information, trade secrets,
technical information, know-how, engineering process, intellectual property,
business plans and strategies, business operations and systems, marketing
techniques, material pricing policies, information concerning employees,
customers, licensees and/or vendors, patent applications, patent prosecution,
inventions, ideas, procedures, formulae or data.  The term Confidential
Information shall not be deemed to include information which (a) is now, or
hereafter becomes, through no act or failure of the Receiving Party, in the
public domain; (b) is known by the Receiving Party at the time of receipt of
such information; (c) is hereafter furnished to the Receiving Party by a third
party, who is not subject to any restriction on disclosure at the time of
disclosure to the Receiving Party; or (d) has been developed by the Receiving
Party completely independent of the delivery of Confidential Information
hereunder.

   C. "Field" shall mean clinical use as a catheter for insertion into the
vascular system of a patient to direct fluid flow, sampling of fluids and
oxygenation monitoring.

                                      1 of 7
<PAGE>

   D. "Licensable Know How" shall mean any and all information, including but
not limited to, confidential, proprietary and trade secret information owned,
controlled, originated, conceived, reduced to practice, developed or otherwise
in the possession of CCF as of the Effective Date necessary to practice
Licensable Patents, including without limitation, all methods, processes,
processing techniques, products, compositions, formulas, test data, and
designs.

   E. "Licensable Patents" shall refer to and mean US Patent Application
# 60/797,433 entitled "Intra-jugular Catheter" and any U.S. or foreign patent
applications, reissues, extensions, renewals, reexaminations, certificates of
invention, substitutions, divisions, continuations, and continuations-in-part
thereof having the Principal Investigator as an inventor and having the same
priority date as the parent applications.

   F. "Licensable Technology" shall mean Licensable Patents and Licensable
Know How.

   G. "Principal Investigator" shall mean Dr. Rafi Avitsian while an
employee of CCF.

2.  OPTION GRANT
    ------------

   2.1  Option Period  For a period of twelve (12) months immediately
        -------------
following the Effective Date of this Agreement ("Option Period"), CCF agrees
that it will not enter into any exclusive agreement with any third party with
respect to the transfer of rights in the Field to the Licensable Technology,
whether by license or otherwise.

   2.2  Negotiation for a License Agreement  During the Option Period, Parties
        -----------------------------------
shall negotiate a License Agreement having terms and conditions generally
agreeable to CCF not limited to but including an upfront license fee,
milestones and a royalty.  Binding obligations for such a license agreement
will only be created by the execution and delivery of a definitive written
agreement between the Parties and shall be dependant on OPTIONEE providing a
product development plan for the Licensable Technology that is acceptable to
CCF at its sole discretion.  If an agreement has not been reached within said
Option Period, the parties shall have no further obligations under this
Agreement and CCF shall be free to license any and all rights under the
Licensable Technology to any third party without any further obligation to
OPTIONEE.

   The license agreement shall include at least the following provisions:
license fees, royalty payments, required terms for granting sublicenses (if
any), a commitment by OPTIONEE and any sublicensee to exert their best
efforts to introduce the licensed material into public use as rapidly as
practicable, the right of CCF to terminate the license should OPTIONEE not
meet specified due-diligence milestones, and indemnity and insurance
provisions satisfactory to CCF.  Provided other terms of a license agreement
negotiated by the Parties upon OPTIONEE's exercise of the Option generally
conform with CCF's standard practices and license terms, such license
agreement shall include financial terms to be negotiated within the following
ranges:  (i) OPTIONEE shall pay CCF a License Fee in amounts that total not
less than eighty thousand dollars ($80,000)  nor more than one hundred
thousand dollars ($100,000); and (ii) OPTIONEE shall remit royalties to CCF
on a quarterly basis based on a percentage of net sales of the products
subject to the license agreement of not less than 7% nor more than 10%.

                                      2 of 7
<PAGE>

3.  PAYMENTS
    --------

   3.1  Option Fee.  Within fifteen (15) days of the Effective Date of this
Agreement, OPTIONEE shall pay CCF a nonrefundable fee equal to ten thousand
dollars ($10,000).

   3.2  Patent Prosecution and Maintenance. CCF shall notify OPTIONEE of any
and all costs associated with prosecuting and maintaining the Licensable
Patents throughout the Option Period, and OPTIONEE shall reimburse CCF up to
$6,500 any and all reasonable costs associated therewith.  Reimbursement
payments shall be due within 15 days of receiving invoices from CCF.  If
OPTIONEE fails to make such reimbursement payments, it shall automatically
relinquish all rights under this Agreement.

4.  INTELLECTUAL PROPERTY RIGHTS
    ----------------------------

   Title to all Licensable Technology (including but not limited to
prototypes developed by the OPTIONEE) shall remain in CCF.  Any materials
developed by OPTIONEE shall be returned to CCF at the end of the Option
Period.

5.  TERMINATION
    -----------

   5.1  Term  Unless otherwise terminated by operation of law or by acts of the
        ----
parties in accordance with the terms of this Agreement, this Agreement shall
automatically terminate upon conclusion of the Option Period.

   5.2  Termination for Breach
        ----------------------

   (a)  This Agreement shall be terminable upon the material breach of either
party.  In the event of a material breach by a party ("Defaulting Party") the
other party ("Non-Defaulting Party") shall give the Defaulting Party written
notice of the default and its termination of this Agreement, subject to a
thirty (30) day right to cure.  If the Defaulting Party (i) fails to cure the
breach within thirty (30) days after receipt of notice from the Non-Defaulting
Party, or (ii) fails to provide a written explanation satisfactory to the Non-
Defaulting Party for the cure or other resolution of the default, then this
Agreement shall be terminated as of the date of the notice.  All termination
rights shall be in addition to and not in substitution for any other remedies
that may be available to the Non-Defaulting Party.

   (b)  Termination pursuant to this section shall not relieve the Defaulting
Party from liability and damages to the Non-Defaulting Party for default.
Waiver by either party of a single default or a succession of defaults shall
not deprive such party of any right to terminate this Agreement arising by
reason of a subsequent default

   5.3  Termination Without Cause.  Either party may terminate this Agreement
        --------------------------
at any time prior to the expiration of the Option Period, by providing  thirty
(30) days written notice of same to the non-terminating party..

   5.4  Effects of Termination.  Any termination of this Agreement for any
        ----------------------
reason, does not relieve either party of any obligation or liability accrued
prior to the termination or rescind anything done by either party and the
termination does not affect in any manner any rights of either party arising
under this Agreement prior to the termination.  Upon expiration of this
Agreement, the obligations set forth in Sections 8, 9.2, 9.3, 9.7 and 9.13,
9.14 shall survive.

                                    3 of 7
<PAGE>

6.  ASSIGNABILITY
    -------------

   This Agreement shall be binding upon and shall inure to the benefit of the
Parties and their respective assigns and successors in interest.  The Agreement
may not be assigned by either Party without the consent in writing of the other
Party.

7.  ADDRESSES
    ---------

   All notices, reports or other required, material communications pursuant to
this Agreement shall be sent to such Party via (i) United States Postal Service
certified mail, return receipt requested, postage prepaid, (ii) overnight
courier, charges prepaid or (iii) facsimile transmission, addressed to it at
its address set forth below or as it shall designate by written notice given to
the other Parties.  Notice shall be sufficiently made or given (a) on the date
of mailing, (b) when deposited with the overnight courier, or (c) when a
facsimile printer reflects receipt.

      CCF:

      CCF Innovations - Mailstop D20
      The Cleveland Clinic Foundation
      500 Euclid Avenue
      Cleveland, OH 44195
      Attn: Neil Veloso
      Facsimile No. 216-445-6514

      With copy to:

      Office of General Counsel
      The Cleveland Clinic Foundation
      3050 Science Park Drive - AC321
      Beachwood, OH 44122
      Attn: Chief Legal Officer
      Facsimile No. 216-448-0201

      OPTIONEE:

      IVPSA Corporation
      500 N. Rainbow, Suite 300
      Las Vegas, NV _89107
      Facsimile No. (702)  221-1963

   8.  DISPUTE RESOLUTION
       ------------------

   8.1  Except in the event that a party shall reasonably determine that it
must seek a preliminary injunction, temporary restraining order or other
provisional relief, upon the occurrence of a dispute between parties,
including, without limitation, any breach of this Agreement or any obligation
relating thereto, the matter shall be referred first to authorized officers of
CCF and OPTIONEE, or their designees.  The authorized officers or their
designees as the CCF may be, shall negotiate in good faith to resolve such
dispute in a mutually satisfactory manner for thirty (30) days.  If such
efforts do not result in mutually satisfactory resolution of the dispute, the
matter shall be handled by arbitration in accordance with Section

                                    4 of 7
<PAGE>

   8.2  Any arbitration shall be conducted in Cleveland, Ohio in accordance
with the Commercial Dispute Resolution Procedures of the American Arbitration
Association and in the English language.  The arbitrators shall include one
nominee of CCF and one nominee of OPTIONEE and a third person selected by said
nominees.  The parties agree that any arbitration panel shall include members
knowledgeable as to evaluation of the biotechnology industry.  Judgment upon
the award rendered may be entered in the highest court or forum, state or
federal, having jurisdiction; provided however, that the provisions of this
Section 8 (Dispute Resolution) shall not apply to any dispute or controversy as
to which any treaty or law prohibits such arbitration.

   8.3  Notwithstanding the foregoing, nothing in this Section 8 shall be
construed to waive any rights or timely performance of any obligations existing
under this Agreement.

9.  ADDITIONAL PROVISIONS
    ---------------------

   9.1  Use of Parties' Names.  Each Party agrees that it shall not use in any
        ---------------------
way the name or logo of the other Party without the prior consent of the Party
whose name is to be used.

   9.2  Independent Contractors.  The Parties hereby acknowledge and agree that
        -----------------------
each is an independent contractor and that no Party shall be considered to be
the agent, representative, master or servant of any other Party for any purpose
whatsoever, and that no Party has any authority to enter into a contract, to
assume any obligation or to give warranties or representations on behalf of any
other Party.  Nothing in this relationship shall be construed to create a
relationship of joint venture, partnership, fiduciary or other similar
relationship between or among the Parties.

   9.3  Indemnification  OPTIONEE shall indemnify, hold harmless and defend CCF
        ---------------
and its respective trustees, officers, employees and agents (the "Indemnitees")
against any and all claims and suits of third parties ("Third Party Claims"),
and any damages, costs, fees, and expenses incurred by the Indemnitees in
connection with such Third Party Claims, resulting from or arising out of this
Option Agreement (each a "Loss").  OPTIONEE shall have no obligation to
indemnify any Indemnitees to the extent that a Loss arises out of the gross
negligence or intentional misconduct of an Indemnitee or the breach of this
Agreement by an Indemnitee.

   9.4  Representations and Warranties.  Each Party represents and warrants
        ------------------------------
that it has the right, power and authority to enter into this Agreement.  CCF
represents and warrants to OPTIONEE that it owns the Licensable Technology.
CCF represents that to its knowledge, as of the Effective Date of this
Agreement, there are no third party infringement claims against the Licensed
Patents.

   9.5  Disclaimer of Further Warranties.  Other than as specifically provided
        --------------------------------
in section 9.4, CCF makes no warranties or representations, express or implied,
with respect to the Licensable Technology including, but not limited to,
warranties of fitness or merchantability.

   9.6  Non-Waiver.  The Parties covenant and agree that if a Party fails or
        ----------
neglects for any reason to take advantage of any of the terms providing for
the termination of this Agreement or if a Party, having the right to declare
this Agreement terminated, shall fail to do so, any such failure or neglect
by such Party shall not be a waiver or be deemed or be construed to be a
waiver of any cause for the termination of this Agreement subsequently
arising, or as a waiver of any of the terms, covenants or conditions of this
Agreement or of the performance thereof.  None of the terms, covenants and
conditions of this Agreement may be waived by a Party except by its written
consent.

                                    5 of 7
<PAGE>

   9.7  Confidentiality.  CCF and OPTIONEE agree for the Term and three (3)
        ---------------
years thereafter to hold all Confidential Information in confidence, and
to use the same only in accordance with this Agreement, unless required to
do so by federal or state securities laws.  OPTIONEE shall have the right to
share Confidential Information with affiliates, partners, and consultants,
provided such third party enters into a confidentiality agreement with
OPTIONEE having terms at least as protective as set forth in this Agreement.
Except as required by applicable law, CCF and the OPTIONEE will hold, and
will cause its respective directors, officers, employees, accountants,
counsel, financial advisors and other representatives and affiliates to
hold, any nonpublic information in confidence.

   9.8  Publications and Copyrights. CCF will be free to publish the results of
        ---------------------------
its research during the Term of this Agreement.

   9.9  Reformation.  The Parties hereby agree that no Party intends to violate
        -----------
any public policy, statutory or common law, rule, regulation, treaty or
decision of any government agency or executive body thereof of any country or
community or association of countries, and that if any word, sentence,
paragraph or clause or combination thereof of this Agreement is found, by a
court or executive body with judicial powers having jurisdiction over this
Agreement or any of the Parties hereto, in a final, unappealable order to be
in violation of any such provision in any country or community or association
of countries, such words, sentences, paragraphs or clauses or combination
shall be inoperative in such country or community or association of countries,
and the remainder of this Agreement shall remain binding upon the Parties
hereto.

   9.10  Execution in Counterparts.  This Agreement may be executed in one or
         -------------------------
more counterparts, each of which shall be deemed to be an original and executed
versions sent by facsimile transmission shall also be deemed to be originals.

   9.11  Disclaimers.  The parties acknowledge and agree that, unless and until
         -----------
the Option is exercised, neither OPTIONEE nor any affiliate of OPTIONEE has any
right or interest in the Licensable Technology.

   9.12  Governing Law  This Agreement shall be governed by the laws of the
         -------------
State of Ohio.

   9.13  Press Releases.  Both OPTIONEE and CCF will not, without the other
         --------------
party's prior review and express written consent, issue any press release, or
issue or make any other public comment, or publish or broadcast any
advertisement in any media, or disseminate any sales promotion or solicitation
materials, that in any way refers to the other party, or any subsidiary or
affiliate of the other party, or to the specific terms of this Agreement unless
such item is substantially similar to that which has already been approved by
the other party.

   9.14  Access to Records.  If Section 952 of the Omnibus Reconciliation Act
         -----------------
of 1980, which amended Section 1861(v)(1) of the Social Security Act, and the
regulations promulgated there under, applies to this Agreement, each party will
make available to the Secretary of Health and Human Services, and to the
Comptroller General of the United States upon written request, such books,
documents and records necessary to verify the nature and extent of the costs of
the services provided hereunder. Access will be granted until the expiration of
four (4) years after the furnishing of services hereunder. Access will also be
granted to any books, documents or records related to this Agreement between a
party and organizations related to that party, but only an as needed basis.

   9.15  Compliance with Laws.  By entering into this Agreement, the parties
         --------------------
specifically intend to comply with all applicable laws, rules and regulations
as they may be amended from time to time. In the event that any part of this
Agreement is determined to violate federal, state, or local laws, rules, or
regulations, the parties agree to negotiate in good faith revisions to the
provision or provisions that are in violation. In the event the parties are
unable to agree to new or modified terms as required to bring the entire
Agreement into compliance, either party may terminate this Agreement without
penalty upon thirty (30) days written notice to the other party.

                                    6 of 7
<PAGE>

   9.16  Debarment.  IVPSA hereby represents and warrants that it has not been
         ---------
debarred, suspended, excluded or otherwise determined to be ineligible to
participate in federal healthcare programs (collectively, "Debarred") and
acknowledges that CCF shall have the right to terminate this Agreement
immediately in the event that IVPSA is Debarred.

   9.17  Conflict.  CCF maintains and adheres to a Conflict of Interest Policy.
         --------
In that connection, OPTIONEE represents that no CCF employees, officers or
directors are employees, consultants, officers or directors of OPTIONEE or
serve on any boards or committees of or in any advisory capacity with OPTIONEE.
Any payments made to such parties are at fair market value for services
rendered.

   IN WITNESS WHEREOF, the Parties hereto have executed and delivered this
Agreement in multiple originals by their duly authorized officers and
representatives on the respective dates shown below, but effective as of the
Agreement Date.

IVPSA CORPORATION                      THE CLEVELAND CLINIC FOUNDATION
(A Nevada Corporation)

By:  /s/ T J Jesky                     By:  /s/ David R. Strand
---------------------                  ------------------------
Name:    T J Jesky                     Name:    David R. Strand
---------------------                  ------------------------
Title:  President/CEO                  Title:  COO
---------------------                  ------------------------
Date:  April 21, 2008                  Date:  April 30, 2008
---------------------                  ------------------------

                                               APPROVED AS TO FORM
                                                  CCF-OFFICE OF
                                                 GENERAL COUNSEL
                                                      BY KDS
                                                         ---
                                                   DATE 4/25/08
                                                        -------
                                                   CMSI# IVPS 25818
                                                         ----------

                                    7 of 7
<PAGE>DUKE MINING COMPANY, INC.

EXHIBIT 10.1

ASSET PURCHASE AGREEMENT

This ASSET PURCHASE AGREEMENT (this “Agreement”) entered into as of this 23rd day of October, 2009, by and among Southwest Resources, Inc., a Delaware company with a principal address of 3001 Knox Street, Suite 403, Dallas, Texas 75205 (“Buyer”), and Duke Mining Company, a Delaware company with a principal address of 850 Third Avenue, Suite 1801, New York, NY 10022 (“Seller”).

BACKGROUND

WHEREAS, Seller is the owner and operator of a mining business (the “Business”); and

WHEREAS, the Buyer desires to acquire certain assets and assume certain liabilities from the Seller relating to the Business; and

NOW, THEREFORE, for and in consideration of the premises and the mutual promises herein made, and in consideration of the representations, warranties, and covenants herein contained, the parties agree as follows.

AGREEMENT

Article I

Purchase and Sale of Assets

Section 1.1

Purchase and Sale of the Purchased Assets.  Upon the terms and subject to the conditions and exceptions contained herein, Seller agrees to sell to Buyer, and Buyer agrees to purchase from Seller all of the Purchased Assets.  For purposes of this Agreement, the term “Purchased Assets” shall mean certain of the assets and rights of the Seller’s, related to the Business as more fully described below:

(a)

Mine Assets.  All assets described on Exhibit A hereto (the “Mine Assets”).

(b)

Contract Rights.  All rights under any agreements, such as executory contracts, operating contracts, purchase and sale orders, including, without limitation, all of Seller’s rights in, to receivables or under any unfilled customer orders payments relating to the Mine Assets (collectively, the “Contract Rights”).

(c)

Permits, Licenses, Etc.  All permits, licenses, franchises, variances, consents or authorizations issued by, and all registrations and filings with, any governmental agency in connection with the Mine Assets to the extent such permits, licenses, franchises, variances, consents, authorizations, registrations and filings are assignable.  

(d)

Other Assets.  All catalogs, technical manuals, customer and supplier lists and records, business goodwill, business and marketing plans, credit files, personnel files, videotapes, photographs, advertising literature and other marketing materials and all other books and records related to the Business.

(e)

Warranties.  All warranties (express or implied) and similar rights and claims related to the Mine Assets.

Section 1.2 

 Lease to Premises.

Buyer agrees and acknowledges that any lease arrangements relating to the Business are to be assumed by Buyer including but not limited to the lease dated November 14, 2008 by and between Premere Resources Corporation and Seller with respect to a 640 acre mining claim located in San Juan County, Utah on Utah School and Institutional Trust Lands Administration, more fully described as Mineral Claim # 50719, legal description as T29sR22E SL. Sec36.  Buyer hereby agrees and acknowledges that it has spoken to Ben Campbell and confirmed that Ben Campbell will recognize the assignment of the Lease and all rights and 

obligations thereunder. Upon transfer of the Purchased Assets to the Buyer as described herein, the Buyer hereby agrees to be bound by and subject to the terms and conditions of the Lease as fully and effectively as if the undersigned had originally executed a counterpart of the Lease together with the other parties thereto.  The undersigned hereby acknowledges having received and reviewed a copy of the Lease.

Section 1.3

Representations and Warranties of Seller.  The Buyer is purchasing the Purchased Assets AS IS and therefore there is no guarantee of the condition, validity or suitability of any purpose or express or implied warranty of any kind related to the Purchased Assets.

Article II

Purchase Price and Closing

Section 2.1

Purchase Price.  Buyer will assume all liabilities of relating to the Purchase Assets, including, but not limited to, the liabilities set forth of Exhibit B hereto.

Section 2.2

No Assumption of Liabilities.  Except as set forth in Section 2.1 above, Buyer shall not assume any liabilities and obligations of Seller, known or unknown, liquidated or unliquidated, accrued or unaccrued, due or to become due, absolute, contingent or fixed (the “Seller’s Liabilities”), including, but not limited to, Buyer shall not assume the following Seller Liabilities (the “Excluded Liabilities”):

(a)

Any Seller Liabilities to or in respect of any temporary or permanent employees or former employees of Seller for any period (collectively, the “Employee Liabilities”), including, without limitation:  (A) any Seller Liability under or with respect to any Employee Benefit Plan, whether or not written, at any time maintained, contributed to by Seller or under which Seller may incur Seller Liability, or any Seller Liability with respect to Seller’s withdrawal or partial withdrawal from or termination of any such plan, program or arrangement; (B) any sick days or personal days; and (C) any claim of an unfair labor practice, for severance pay or under any state unemployment compensation law or regulation or under any federal or state employment discrimination law or regulation, whether or not such Seller Liabilities are described, listed or referred to on any Schedule or Exhibit hereto, including any Seller Liability for severance or COBRA arising from Seller’s termination of said employees;

(b)

Any Seller Liabilities in respect of injury to or death of any person, animal or damage to or destruction of any property, whether based on negligence, breach of warranty, strict liability, enterprise liability or any other legal or equitable theory, whether or not such Seller Liabilities are described, listed or referred to on any Schedule or Exhibit hereto;

(c)

All Seller Liabilities for Taxes (as hereinafter defined), including Taxes relating to the sale of the Purchased Assets to Buyer.  “Tax” or “Taxes” means any federal, state, local, or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental (including taxes under Section 59Aof the Internal Revenue Code, as amended (the “Code”)), customs duties, capital stock, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated or other tax of any kind whatsoever, including any interest, penalty or addition thereto, whether disputed or not.

(d)

All Seller Liabilities directly or indirectly resulting from or arising out of Seller’s entering into, performing its obligations pursuant to, or consummating the transactions contemplated by, this Agreement, including, without limitation, all legal and other professional fees; and

(e)

Except as set forth in Section 2.1, all promissory notes, letters of credit and guaranties.

Section 2.3

The Closing.  The consummation of the transactions contemplated by Sections 1.1 and 2.1 shall constitute the Closing.  The Closing shall take place at such other time or place or on such other date as shall be mutually agreed upon by the Seller and Buyer, which date shall constitute the Closing Date.

Section 2.4

Transfer Documents.  To effect the transfer of the Purchased Assets in accordance with this Agreement at the Closing, Seller shall execute and deliver to Buyer documents consistent with the terms of this Agreement and satisfactory to Buyer's Counsel, including the following:

(a)

a warranty bill of sale containing such warranties as are consistent with the terms of this Agreement, pursuant to which Seller conveys to Buyer the Purchased Assets.  Seller shall take all steps that may be reasonably requested by Buyer to put Buyer in actual possession, operation and control of the Purchased Assets;

(b)

assignments or other documents of transfer, whereby Seller transfers to Buyer all Proprietary Rights and Contract Rights, in recordable form to the extent necessary or appropriate to assign such rights;

(c)

certain of the Books and Records related to the Purchased Assets; 

(d)

such other instruments and documents as shall be reasonably requested by Buyer to vest in Buyer good and valid title in and to the Purchased Assets in accordance with the provisions hereof.

All of the foregoing described instruments shall be in form and substance and shall be executed and delivered in a manner consistent with the terms of this Agreement and prepared by Buyer and Buyer's Counsel in their reasonable discretion.

Article III

Representations and Warranties

Section 3.1

Representations and Warranties of Seller.  Seller represents and warrants to Buyer that the statements contained in this Section 3.1 are correct and complete as of the date hereof and will be correct and complete as of the Closing Date.

(a)

Organization and Qualification.  Seller warrants and represents that Seller is validly existing, and in good standing under the laws of the State of Delaware and has all requisite power and authority to carry on the business as it is presently being conducted, to enter into this Agreement, and to carry out and perform the terms and provisions of this Agreement.  

(b)

Authorization of Transaction.  Seller has full power and authority to execute and deliver this Agreement and to perform its respective obligations hereunder.  This Agreement and all related agreements executed by Seller have been duly executed and delivered by Seller and constitute valid and legally binding obligations of Seller, enforceable against him in accordance with their terms and conditions.  Seller does not need to give any notice to, make any filing with, or obtain any authorization, consent or approval of any government or governmental agency in order to consummate the transactions contemplated by this Agreement.

(c)

Legal Compliance.  Seller has complied with all applicable laws (including rules, regulations, codes, plans, injunctions, judgments, orders, decrees, rulings and charges thereunder) of federal, state, local and foreign governments (and all agencies thereof), and no action, suit, Proceeding, arbitration, audit, suit, hearing, investigation, charge, complaint, claim, demand or notice, whether civil, criminal, administrative investigative, or informal (“Proceeding”) has been filed or commenced against any of them alleging any failure so to comply.  Seller warrants and represents that Seller except as related to the Lease, to the best of the Seller’s knowledge, the Seller is not in violation of any term or provision of any charger, bylaw, mortgage, indenture, contract, agreement, instrument, judgment, decree, order, statute, rule or regulation; and Seller's execution and delivery of, and performance and compliance with, this Contract will not result in the violation of, or be in conflict with, or constitute a default under, any term or provision of the foregoing, or result in the creation of any mortgage, lien, encumbrance, or charge on any of the properties or assets of Seller pursuant to any such term or provision.

(d)

Tax Matters. 

(i)

Seller has filed all Tax returns that he was required to file.  All such Tax returns were correct and complete in all respects.  All Taxes owed by Seller as shown on said Tax returns have been paid. Seller currently is not the beneficiary of any extension of time within which to file any Tax return.  No claim has been made by an authority in a jurisdiction where Seller does not file Tax returns that it is or may be subject to taxation by that jurisdiction.  There are no security interests, other than liens for Taxes not yet due and payable, on any of the assets of Seller that arose in connection with any failure (or alleged failure) to pay any Tax;

(ii)

Seller has withheld and paid all Taxes required to have been withheld and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, or other third party;

(iii)

No authority is expected to assess any additional Taxes for any period for which Tax returns have been filed.  There is no dispute or claim concerning any Tax Liability of Seller either (A) claimed or raised by any authority in writing, or (B) as to which Seller has knowledge;

(iv)

Seller has not waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency;

(g)

Liability.  Seller does not have any Liability (and there is no reasonable basis for any present or future Proceeding against Seller giving rise to any Seller Liability) arising out of any injury to individuals, animals or property as a result of the ownership, possession or use of any asset in the Business.  There are no facts, which Seller believes will lead to such a Seller Liability, asserted or otherwise.

(h)

Employees.  Seller is not a party or aware of any discrimination claims, sexual harassment claims, claims of unfair labor practices or employment claims.  

(i)

No Material Change Through Closing.  Seller is aware of no event or occurrence that materially adversely affects the purchased assets, the Business property, Premises, financial condition or operation of this Business.

Section 3.2

Representations and Warranties of Buyer.  Buyer represents and warrants toSeller that the statements contained in this Section 3.2 are correct and complete as of the date hereof and will be correct and complete as of the Closing Date.

(a)

Organization and Qualification.  Buyer warrants and represents that Buyer is validly existing, and in good standing under the laws of the State of Delaware and has all requisite power and authority to carry on the business as it is presently being conducted, to enter into this Agreement, and to carry out and perform the terms and provisions of this Agreement. 

(b)

Authorization of Transaction.  Buyer has full power and authority to execute and deliver this Agreement and to perform its respective obligations hereunder.  This Agreement and all related agreements executed by Buyer have been duly executed and delivered by Buyer and constitute valid and legally binding obligations of Buyer, enforceable against it in accordance with their terms and conditions.  Buyer does not need to give any notice to, make any filing with, or obtain any authorization, consent or approval of any government or governmental agency in order to consummate the transactions contemplated by this Agreement.

Article IV

Conditions to Closing

Section 4.1

Conditions to Obligation of Buyer.  The obligation of Buyer to consummate the transactions to be performed by it in connection with the Closing is subject to satisfaction of the following conditions:

(a)

the representations and warranties set forth in Sections 1.3 and 3.1 above shall be true and correct in all material respects at and as of the Closing;

(b)

Seller shall have performed and complied with all of their covenants hereunder in all material respects through the Closing;

(c)

No Proceeding shall be pending or threatened wherein an unfavorable injunction, judgment, order, decree, ruling or charge would (A) prevent consummation of any of the transactions contemplated by this Agreement, (B) cause any of the transactions contemplated by this Agreement to be rescinded following consummation, or (C) affect adversely the right of Buyer to own the Purchased Assets.

All actions to be taken by the Seller in connection with consummation of the transactions contemplated hereby and all certificates, instruments, and other documents required to effect the transactions contemplated hereby will be satisfactory in form and substance to Buyer with all deliberate speed.  Buyer may waive any condition specified in this Section 4.1 if it executes a writing so stating at or prior to the Closing.

Article V

Intentionally Deleted

Article VI

General

Section 6.1

Survival of Representation and Warranties.  All representations, warranties, covenants and delivery requirements set forth in this Agreement shall survive the closing for a period of six (6) months.

Section 6.2

Damage or Destruction of Purchased Assets.  If any of the Purchased Assets are damaged or destroyed prior to closing, Seller must promptly notify Buyer.  Buyer will thereupon have the right, at its option, to elect to terminate this Agreement without liability, or to proceed to the Closing and accept all insurance proceeds received as a result of any damage or destruction.  Risk of loss of, or damage or destruction to, the Property will be borne by Seller until the Closing.

Section 6.3

Entire Agreement.  This Agreement (including the documents referred to herein) constitutes the entire agreement among the parties and supersedes any prior understandings, agreements or representations by or among the parties, written or oral, to the extent they related in any way to the subject matter hereof.

Section 6.4

Governing Law.  This Agreement shall be governed by and construed in accordance with the domestic laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule that would cause the application of the laws of any jurisdiction other than the State of Delaware.

Section 6.5

Notices.  Any notices or other communications required or permitted under this Agreement shall be sufficiently given if delivered personally or sent by registered or certified mail, postage prepaid, addressed to Seller at c/o Duke Mining Company, 850 Third Avenue, Suite 1801, New York, NY 10022 or Buyer at c/o Southwest Resources, Inc, or at any other address furnished in writing by either party to the other, and shall be deemed to have been given as of the date delivered or deposited in the United States mail, as the case may be.

Section 6.6

Parties in Interest.  All the terms and provisions of this Agreement shall be binding on and inure to the benefit of, and be enforceable by, Seller and Buyer and their successors and assigns.

Section 6.7

Seller's Further Cooperation.  Seller agrees to cooperate with Buyer in the transition of ownership of the Business and provide Buyer with reasonable assistance during the transition of same.

Section 6.8

Brokers.  Seller warrants and represents that the introduction of Seller to Buyer and all negotiations on the part of Seller relative to this Agreement and the transaction contemplated by this Agreement have been effected and carried on by Seller directly with Buyer without intervention of any broker, finder, or other person.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

		
	         

	Duke Mining Company

	 
	  

	 
	 

	 
	/s/ Benjamin Mayer

	 
	By: Benjamin Mayer

	 
	Its: President and Chairman of the Board

		
	         

	Southwest Resources, Inc.

	 
	  

	 
	 

	 
	/s/ Dennis G. McLaughlin III

	 
	By: Dennis G. McLaughlin III

	 
	Its: Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]